IOL Chemicals And Pharmaceuticals dividend 2025

IOLCP

102.78

1.51 (1.49%)
Last updated on 30 Sep, 2025 | 15:59 IST
BUYSELL

The current prices are delayed, login to your account for live prices

IOL Chemicals And Pharmaceuticals Dividend Details

Record Date

18-Feb-2025

Ex Date

18-Feb-2025

Dividend Type

Equity Share

Dividend Per Share

40.00

IOL Chemicals And Pharmaceuticals Dividend History

Record DateDividend Per ShareDividend TypeEx-Date
18-Feb-20250.40Equity Share18-Feb-2025

Upcoming Dividends by Indian Companies

View More
CompanyDividends RatioAnnouncementRecord DateDividends Date
ICICI Lombard General Insurance Company Ltd.025-Sep-202523-Oct-202523-Oct-2025
Tata Consultancy Services Ltd.022-Sep-202515-Oct-202515-Oct-2025
Rashtriya Chemicals and Fertilizers Ltd.0.13227-May-202510-Oct-202510-Oct-2025
Glenmark Pharmaceuticals Ltd.2.522-Sep-202503-Oct-202503-Oct-2025

IOL Chemicals And Pharmaceuticals Dividend FAQs

The latest dividend declared by IOL Chemicals And Pharmaceuticals is of 0.4 per share for the financial year as announced on 18-Feb-2025.

Registered shareholders who own IOL Chemicals And Pharmaceuticals’s shares on or before the record date of 18-Feb-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 18-Feb-2025.

You can expect to receive IOL Chemicals And Pharmaceuticals’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 18-Feb-2025. The record date is when IOL Chemicals And Pharmaceuticals identifies eligible shareholders for the dividend payment.

The annual dividend paid by IOL Chemicals And Pharmaceuticals varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine IOL Chemicals And Pharmaceuticals's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.